Venlafaxine Hydrochloride extended release capsules, 37.5 mg, 30-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc. 2400 Route 130 North, Dayton, NJ 08810 Manufactured by: Aurobindo Pharma Limited Hyderabad-500 072 India, NDC 65862-527-30
Published February 22, 2017 · Recall initiated: December 22, 2016
Summary
FDA records drug Class II recall D-0474-2017, published February 22, 2017 and initiated December 22, 2016. Recalling firm: Aurobindo Pharma USA Inc; Status: Terminated; Reported quantity: 47,040 bottles; Lot: Lot #: VI3716010-A, Exp. 04/2018. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Tablet/Capsule Specifications: Some bottles contain punctured, and/or clumped/melted capsules.
What to do
Voluntary: Firm initiated · Letter
Get an email if VENLAFAXINE HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- VENLAFAXINE HYDROCHLORIDE
- Manufacturer
- Aurobindo Pharma USA Inc
- Distributor
- Nationwide in the US
- UPC
- 0365862528476
- Lot
- Lot #: VI3716010-A, Exp. 04/2018
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAVenlafaxine Hydrochloride Extended-Release Capsules, USP 37.5mg, packaged in a) 90-count bottles (NDCJuly 31, 2024
- FDASLIMFIT X capsules, packaged in a 60-cont bottleFebruary 22, 2017
- FDAGlipizide extended-release tablets, 2.5mg, 30-count bottle, Rx Only, Manufactured By Patheon PharmaceuticalsFebruary 22, 2017
- FDAMegaJex Herbal Supplement, Maximum Formula for Men, Fast acting, Increase Stamina, 20 capsules, MS Bionics,February 22, 2017
- FDAVenlafaxine HCL ER Capsule USP, 150mg, packaged in a) 30-count bottles (NDC 68382-036-06), b) 90-count bottlesAugust 24, 2016
- FDAVenlafaxine HCL ER Capsule USP, 75mg, packaged in a) 30-count bottles (NDC 68382-035-06), b) 90-count bottlesAugust 24, 2016
Questions about this recall
Was Venlafaxine Hydrochloride extended release capsules, 37.5 mg, 30-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc. 2400 Route 130 North, Dayton, NJ 08810 Manufactured by: Aurobindo Pharma Limited Hyderabad-500 072 India, NDC 65862-527-30 recalled?
Yes. FDA published recall D-0474-2017 on February 22, 2017. Reported hazard: Failed Tablet/Capsule Specifications: Some bottles contain punctured, and/or clumped/melted capsules.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: VENLAFAXINE HYDROCHLORIDE. UPC: 0365862528476.